Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
Phase of Trial: Phase III
Latest Information Update: 01 Aug 2017
At a glance
- Drugs Dexamethasone (Primary) ; Methotrexate (Primary) ; Ranibizumab (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- Acronyms MERIT
- 25 Jul 2017 Status changed from not yet recruiting to recruiting.
- 13 Oct 2016 Planned initiation date changed from 1 Apr 2016 to 1 Nov 2016.
- 10 Dec 2015 New trial record